Eli Lilly fails to beat Pfizer's migraine drug in head-to-head clinical trial
When it comes the new class of CGRP drugs against migraine, Pfizer most likely owns the best of the kind, namely oral Nurtec ODT.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
NICE approves migraine wafer from Pfizer
For subscribers
NICE recommends Lundbeck migraine drug
For subscribers